Skip to content

KLRS KLRS Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$297K+2.1%
PVL
Palvella TherapeuticsPVLA
$38.5K

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Reported directly by KLRS in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: KLRS’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's payments of stock issuance costs?
KLRS (KLRS) reported payments of stock issuance costs of $417.25K in Q4 2025.
What does payments of stock issuance costs mean?
Tracks the direct cash expenditures incurred in the process of issuing new equity, such as legal, accounting, and underwriting fees. This metric represents the friction cost of raising capital and is deducted from the gross proceeds of equity offerings. Monitoring these costs helps evaluate the efficiency of the company's capital-raising efforts.